Empagliflozin and linagliptin
Empagliflozin and linagliptin is a combination of two medicines used to help improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. Empagliflozin is an SGLT2 inhibitor that increases glucose removal through the urine, while linagliptin is a DPP-4 inhibitor that helps support the body's insulin response after meals and reduces glucose released by the liver.
In the United States, all represented products are prescription medicines.
Our empagliflozin and linagliptin option
We currently offer Glyxambi as film-coated tablets in the 10 mg + 5 mg strength. Package options include 30, 60, 90, and 180 tablets, letting you select the quantity that fits your prescribed treatment and ordering preferences.
- Form: Film-coated tablet
- Strength: 10 mg + 5 mg
- Package quantities: 30, 60, 90, or 180 tablets
- Price range: $102.00 to $558.00
- Lowest listed price per tablet: $3.10, based on the 180-tablet package priced at $558.00
Package size changes the total package price and may affect the per-tablet value; it does not change the stated tablet strength. Follow the directions provided by your prescriber and pharmacist, and discuss questions about suitability, use with other medicines, or possible side effects with a qualified healthcare professional.
Ordering, payment, and shipping
You can order Glyxambi from us online. We accept Visa, Mastercard, American Express, Discover, and Bitcoin or USDT.
We offer Express shipping for $29.99 with tracking, with an estimated delivery time of 4 to 7 days. Standard shipping costs $14.99, does not include tracking, and has an estimated delivery time of 14 to 21 days. Free shipping may be available when the applicable threshold is met; you will see the final total and available delivery options at checkout.
Customer experience
One Glyxambi customer noted that our support team corrected a shipping-address typo before the order was dispatched. Another shared that the tablet's color and shape differed from a version they had previously used, while emphasizing the same empagliflozin and linagliptin combination. Individual experiences can vary.
















